Contract 36C24122A0124
Adaptive Biotechnologies Corporation · Department Of Veterans Affairs · May 13, 2025
Adaptive Biotechnologies Corporation was awarded a federal contract by Department Of Veterans Affairs on May 13, 2025 for an undisclosed amount of work in research and development in biotechnology (except nanobiotechnology). The contract has been modified 2 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on June 23, 2026. If all options are exercised, the contract could reach $829,000.
Contract details
- PIID
- 36C24122A0124
- Award type
- Bpa
- Pricing
- Firm Fixed Price
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Reference Laboratory Testing
- First action
- May 13, 2025
- Latest action
- June 23, 2026
Description
EO 14398
Modification timeline
-
June 23, 2026Mod P00003 · Supplemental Agreement For Work Within Scope$0
-
March 12, 2026Mod P00002 · Other Administrative ActionCLONOSEQ TESTING FOR VISN 1 ADMINISTRATIVE MODIFICATION TO ADD CLINS TO CONTRACT FILE$0
-
May 13, 2025Mod P00001$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Washington State University | Department Of Veterans Affairs | July 1, 2026 | $52.0K |
| Duke University | Department Of Veterans Affairs | July 1, 2026 | $1.71M |
| University Of Wisconsin System | Department Of Veterans Affairs | July 1, 2026 | $135.7K |
| Regents Of The University Of California, The | Department Of Veterans Affairs | June 29, 2026 | $11.8K |
| Twist Bioscience Corporation | Department Of Veterans Affairs | June 24, 2026 | $47.5K |
| Transnetyx, Inc | Department Of Veterans Affairs | June 23, 2026 | $35.5K |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36C24122A0124?
Contract 36C24122A0124 is a federal contract awarded to Adaptive Biotechnologies Corporation by Department Of Veterans Affairs on May 13, 2025 for an undisclosed amount of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 2 times since the base award.
Who won contract 36C24122A0124?
Adaptive Biotechnologies Corporation won contract 36C24122A0124 from Department Of Veterans Affairs.
How much is contract 36C24122A0124 worth?
Contract 36C24122A0124 has obligated $0 to date but carries a potential ceiling of $829,000 if fully funded and all options are exercised.